Skip to main content
. 2021 Nov 25;10(6):109–121. doi: 10.5527/wjn.v10.i6.109

Table 6.

Adverse events (n = 37)

Adverse events
No. of patients (%)
No. of events
Total 18 (48.65) 39
Blood and lymphatic disorders
Bicytopenia1 1 (2.70) 1
Gastrointestinal disorders
Diarrhea 1 (2.70) 1
Nausea 1 (2.70) 1
Infections and infestations
Exit site infection/inflammation 6 (16.22) 6
Pneumonia1 2 (5.40) 2
Eosinophilic peritonitis 2 (5.40) 2
Injury, poisoning and procedural complications
Closed fractures of femur1 1 (2.70) 1
Accidental tear small bowel1 1 (2.70) 1
Investigations
Hyperkalemia 1 (2.70) 1
Hypokalemia 1 (2.70) 1
Hyperphosphatemia 1 (2.70) 1
Metabolism and nutrition disorders
Hypoglycemia 2 (5.40) 2
Musculoskeletal and connective tissue disorders
Acute arthritis 1 (2.70) 1
Nervous system disorders
Headache 1 (2.70) 1
Dizziness 1 (2.70) 1
Renal and urinary disorders
Volume overload1,2 1 (2.70) 1
Respiratory, thoracic and mediastinal disorders
Chest discomfort 1 (2.70) 1
Bronchospasm 1 (2.70) 1
Pleural effusion1 1 (2.70) 1
Skin and subcutaneous tissue disorders
Edema 4 (10.81) 4
Paleness 1 (2.70) 2
Cellulitis 1 (2.70) 1
Itching from dry skin 1 (2.70) 1
Surgical and medical procedures
Catheter malfunction/ malposition3 2 (5.40) 2
Vascular disorder
Hypertensive urgency1,4 2 (5.40) 2
1

Serious adverse event.

2

Severe adverse event.

3

Only one out of two events were serious adverse event.

4

The causality was deemed as probable.